Spire Wealth Management Moderna, Inc. Transaction History

Spire Wealth Management

$3.01 Billion
Q1 2024

A detailed history of Spire Wealth Management transactions in Moderna, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 1,308 shares of MRNA stock, worth $154,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,308

Previous 1,111 17.73%

Holding current value

$154,762

Previous $110,000 26.36%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$85.37 - $115.44 $16,817 - $22,741	197 Added 17.73%	1,308 $139,000
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $88,208 - $132,521	-1,269 Reduced 53.32%	1,111 $110,000
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $30,272 - $39,755	314 Added 15.2%	2,380 $245,000
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $26,662 - $36,119	-225 Reduced 9.82%	2,066 $251,000
Q1 2023 May 09, 2023	SELL	$135.66 - $197.02 $40,155 - $58,317	-296 Reduced 11.44%	2,291 $351,000

Q4 2022 Feb 03, 2023	SELL	$118.38 - $210.04 $19,295 - $34,236	-163 Reduced 5.93%	2,587 $465,000
Q3 2022 Nov 07, 2022	SELL	$118.07 - $194.18 $27,864 - $45,826	-236 Reduced 7.9%	2,750 $325,000
Q2 2022 Jul 22, 2022	BUY	$117.13 - $176.59 $197,598 - $297,907	1,687 Added 129.87%	2,986 $427,000
Q1 2022 Apr 18, 2022	SELL	$126.46 - $235.05 $80,428 - $149,491	-636 Reduced 32.87%	1,299 $224,000
Q4 2021 Jan 14, 2022	SELL	$225.82 - $368.51 $595,035 - $971,023	-2,635 Reduced 57.66%	1,935 $491,000
Q3 2021 Oct 22, 2021	BUY	$221.9 - $484.47 $363,028 - $792,592	1,636 Added 55.76%	4,570 $1.77 Million
Q2 2021 Jul 26, 2021	BUY	$129.91 - $234.98 $135,755 - $245,554	1,045 Added 55.32%	2,934 $749,000
Q1 2021 May 21, 2021	BUY	$109.18 - $185.98 $206,241 - $351,316	1,889 New	1,889 $239,000

Others Institutions Holding MRNA

# of Institutions

1,039

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Account

Spire Wealth Management Moderna, Inc. Transaction History